# Global health risks and complications of RSV

> Live situation record from CLSTR: https://clstr.news/situations/global-impact-of-respiratory-syncytial-virus
> Updated: 2026-09-09T16:45:19.000Z. Sources: 13. Developments: 4.

Respiratory Syncytial Virus (RSV) continues to pose a significant global health threat, particularly to infants and the elderly. Medical experts highlight that the virus causes millions of infant hospitalizations annually and is a leading cause of bronchiolitis and pneumonia.

In Vietnam, health officials noted that approximately 9 out of 10 children are estimated to contract the virus within their first two years of life. Dr. Truong Huu Khanh warned that severe infections in the first year can result in long-term complications such as asthma and reduced lung function.

In Poland, medical professionals at the Institute of Mother and Child in Warsaw have observed that nearly 95% of children hospitalized for RSV had no prior risk factors for severe disease. Dr. Alicja Karney emphasized that effective prevention is crucial to reducing the burden on pediatric healthcare systems. Transmission often occurs through close contact, with approximately 54.8% of pediatric cases stemming from the immediate environment.

Recent research and medical warnings emphasize the dangers of co-infections and long-term impacts. In young children, the simultaneous circulation of RSV alongside Adenovirus and bacteria like Streptococcus pneumoniae or Haemophilus influenzae can lead to respiratory failure, meningitis, and sepsis. 

A systematic review led by Duke-NUS Medical School, analyzing over 631,000 people, indicates that these viruses can cause lingering health issues for months. While lung dysfunction is a frequent complication following influenza, heart-related events were most consistently observed after RSV infections. For those with cardiovascular conditions, the inflammation and oxygen deficiency caused by such infections can trigger acute cardiac events, including increased risks for myocardial infarction.

## Timeline

### 2026-09-09: Respiratory viruses linked to long-term lung and heart complications

A major review shows influenza and RSV can cause long-term lung and heart issues, highlighting the importance of seasonal vaccinations for COVID-19, flu, and RSV.

2 sources. https://clstr.news/cluster/respiratory-viruses-linked-to-long-term-lung-and-heart-complications

### 2026-09-06: Respiratory infections pose severe risks to children and heart patients

Medical experts warn that respiratory infections like RSV and influenza pose severe risks, including dangerous co-infections in children and increased cardiovascular complications in heart patients.

3 sources. https://clstr.news/cluster/respiratory-infections-pose-severe-risks-to-children-and-heart-patients

### 2026-09-02: RSV poses high risks to infants and seniors

Experts warn that RSV is a major cause of infant hospitalization and poses high risks to seniors, emphasizing the need for prevention to reduce the burden on healthcare systems.

5 sources. https://clstr.news/cluster/rsv-poses-high-risks-to-infants-and-seniors

### 2026-08-22: Respiratory Syncytial Virus causes 2.2 million infant hospitalizations annually

Respiratory Syncytial Virus (RSV) causes 2.2 million infant hospitalizations annually worldwide, potentially leading to long-term respiratory issues like asthma and reduced lung function.

3 sources. https://clstr.news/cluster/respiratory-syncytial-virus-causes-22-million-infant-hospitalizations-annually

---
Cite as: Global health risks and complications of RSV. CLSTR, https://clstr.news/situations/global-impact-of-respiratory-syncytial-virus